Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Fralick

Showing results (71-80 of 196) with videos related to

Pageof 20
Sort By:
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|June 24, 2020
Good things come in threes (and sometimes fours): Update on renin-angiotensin-aldosterone system inhibitors and COVID-19Kieran L Quinn, Michael Fralick, Jonathan S Zipursky, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|April 26, 2020
Renin-angiotensin-aldosterone system inhibitors and COVID-19Kieran L Quinn, Michael Fralick, Jonathan S Zipursky, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|November 3, 2020
Kieran L Quinn, Michael Fralick, Jonathan S Zipursky, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|July 1, 2020
Further developments in the literature on RAAS inhibitors and COVID-19Kieran L Quinn, Michael Fralick, Jonathan S Zipursky, et al.
Plos One|February 9, 2023
Identifying drugs with the greatest increases and decreases in spending per beneficiary using Medicare Part D: A cross-sectional studyBenazir Hodzic-Santor, Chana A Sacks, Tamara Van Bakel, et al.
Diabetes, Obesity & Metabolism|June 18, 2021
Using machine learning to predict severe hypoglycaemia in hospitalMichael Fralick, David Dai, Chloe Pou-Prom, et al.
The Lancet. Haematology|June 27, 2024
The origin of ferritin reference intervals: a systematic reviewJudy Truong, Kanza Naveed, Daniel Beriault, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 25, 2020
Using Data From Routine Care to Estimate the Effectiveness and Potential Limitations of Outcomes-Based Contracts for Diabetes MedicationsMichael Fralick, Joshua J Gagne, Elisabetta Patorno, et al.
Journal of General Internal Medicine|February 17, 2018
Application and impact of run-in studiesMichael Fralick, Jerry Avorn, Jessica M Franklin, et al.
American Journal of Nephrology|November 24, 2025
Building and Prospectively Evaluating a Prediction Model to Forecast Urgent Dialysis Needs across Four Tertiary HospitalsBryant Lim, Kevin Zhu, Katarina Zorcic, et al.
Pageof 20

Showing results (71-80 of 196) with videos related to

Sort By:
Pageof 20
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|June 24, 2020
Good things come in threes (and sometimes fours): Update on renin-angiotensin-aldosterone system inhibitors and COVID-19Kieran L Quinn, Michael Fralick, Jonathan S Zipursky, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|April 26, 2020
Renin-angiotensin-aldosterone system inhibitors and COVID-19Kieran L Quinn, Michael Fralick, Jonathan S Zipursky, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|November 3, 2020
Kieran L Quinn, Michael Fralick, Jonathan S Zipursky, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|July 1, 2020
Further developments in the literature on RAAS inhibitors and COVID-19Kieran L Quinn, Michael Fralick, Jonathan S Zipursky, et al.
Plos One|February 9, 2023
Identifying drugs with the greatest increases and decreases in spending per beneficiary using Medicare Part D: A cross-sectional studyBenazir Hodzic-Santor, Chana A Sacks, Tamara Van Bakel, et al.
Diabetes, Obesity & Metabolism|June 18, 2021
Using machine learning to predict severe hypoglycaemia in hospitalMichael Fralick, David Dai, Chloe Pou-Prom, et al.
The Lancet. Haematology|June 27, 2024
The origin of ferritin reference intervals: a systematic reviewJudy Truong, Kanza Naveed, Daniel Beriault, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 25, 2020
Using Data From Routine Care to Estimate the Effectiveness and Potential Limitations of Outcomes-Based Contracts for Diabetes MedicationsMichael Fralick, Joshua J Gagne, Elisabetta Patorno, et al.
Journal of General Internal Medicine|February 17, 2018
Application and impact of run-in studiesMichael Fralick, Jerry Avorn, Jessica M Franklin, et al.
American Journal of Nephrology|November 24, 2025
Building and Prospectively Evaluating a Prediction Model to Forecast Urgent Dialysis Needs across Four Tertiary HospitalsBryant Lim, Kevin Zhu, Katarina Zorcic, et al.
Pageof 20